(Q51147328)

31 March 2018

title

Clinical and economic burden of pneumococcal disease in older US adults. (English)

1 reference

31 March 2018

5

Lisa A Jackson

1 reference

31 March 2018

author name string

Derek Weycker

1

1 reference

31 March 2018

David Strutton

2

1 reference

31 March 2018

John Edelsberg

3

1 reference

31 March 2018

Reiko Sato

4

1 reference

31 March 2018

language of work or name

English

0 references

publication date

22 May 2010

1 reference

31 March 2018

published in

Vaccine

1 reference

31 March 2018

volume

28

1 reference

31 March 2018

issue

31

1 reference

31 March 2018

page(s)

4955-4960

1 reference

31 March 2018

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Microbiological profile of community-acquired pneumonia in adults over the last 20 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Predicting bacteremia in patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Treatment costs of community-acquired pneumonia in an employed population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Cost-effectiveness of the pneumococcal vaccine in healthy younger adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

6th International Symposium on Pneumococci and Pneumococcal Diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

The burden of community-acquired pneumonia in seniors: results of a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.030

10.1016/J.VACCINE.2010.05.030

7 January 2021

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018